ARDSLEY ADVISORY PARTNERS LP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 900529
Norwalk, CT
Position in TEVA
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$15,754,200
-$962,400 QoQ
Shares Held
465,000
-16.2% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
1.76%
of 13F equity value
Holder Rank
#120
of 671 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARDSLEY ADVISORY PARTNERS LP holds $32,009,100 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (49.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
30,000 | $16,254,900 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
465,000 | $15,754,200 |
All Filings in TEVA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,754,200 | 465,000 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $16,716,600 | 555,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,101,800 | 580,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,100,000 | 500,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,704,000 | 400,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,685,000 | 500,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,612,000 | 300,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,359,258 | 352,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,074,687 | 250,750 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||